🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07037017
Recruiting Not applicable

CBT Effects on Neural, Physiological, and Attentional Responses in Anorexia Nervosa

NCT07037017 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-05-15
Last updated
2025-06-25

Condition(s) studied

Eating Disorders (Excluding Anorexia Nervosa)

Investigational drug(s) / intervention(s)

Cognitive-Behavioral Therapy

Cognitive-Behavioral Therapy: Manualized 12-week CBT protocol focused on reducing body image disturbance, distorted beliefs about food and appearance, and avoidance behaviors in individuals with anorexia nervosa. The intervention incorporates psychoeducation, cognitive restructuring, emotional regulation, food exposure, and body image work.

Study summary

This randomized controlled trial investigates the neurophysiological, physiological, and attentional effects of Cognitive-Behavioral Therapy (CBT) in individuals with restrictive-type anorexia nervosa (AN). The study compares two groups: one receiving a 12-week CBT intervention, and one placed on a waitlist (no active treatment during the study period). All participants undergo pre- and post-intervention assessments using electroencephalography (EEG), galvanic skin response (GSR), and eye-tracking while exposed to visual stimuli related to food, body image, and self-appearance. The primary outcomes include neural changes in attention and emotional processing (P300, LPP, frontal alpha asymmetry), physiological arousal (skin conductance), and visual attention biases (fixation duration and gaze distribution). The aim is to determine whether CBT leads to measurable improvements in neurobiological and attentional mechanisms related to body image disturbance and food-related anxiety in AN, contributing to biomarker-informed psychotherapy approaches.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
35 Years
Healthy volunteers
No
Inclusion Criteria: * Female participants aged 18 to 35 * Meeting DSM-5 diagnostic criteria for restrictive-type anorexia nervosa * Body Mass Index (BMI) between 15.0 and 18.5 * Medically stable to participate in psychological and neurophysiological assessments * Willingness to participate in weekly therapy sessions (for the CBT group) and to complete pre- and post-assessments * Ability to provide informed consent Exclusion Criteria: * Current or past diagnosis of bulimia nervosa, binge-eating disorder, or other eating disorders * Presence of comorbid severe psychiatric disorders (e.g., psychosis, bipolar disorder, substance use disorder) * History of neurological illness or traumatic brain injury * Use of psychotropic medication within the last 6 weeks * Prior participation in structured Cognitive-Behavioral Therapy for an eating disorder * Pregnancy * Visual or neurological impairments that would prevent accurate EEG, GSR, or eye-tracking recordings

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Üsküdar University Neuro Marketing Lab. Istanbul Turkey (Türkiye) Recruiting

More Istanbul Nisantasi University trials in Turkey

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07037017 on ClinicalTrials.gov ↗ ← All trials in Turkey